We report herein a case of primary cutaneous zygomycosis caused by Rhizopus oryzae in a 7-year-old girl with acute lymphoblastic leukemia (ALL) receiving intensive chemotherapy. The diagnosis was based on observation of hyphal elements in cutaneous biopsy and isolation of the fungus in culture. The patient responded to surgical intervention and treatment with amphotericin B.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1111/j.1439-0507.2004.01051.x | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
The COVID-19-Associated Mucormycosis with Cutaneous Involvement.
Skinmed
October 2024
Department of Dermatology, All India Institute of Medical Sciences, Raipur, Chhattisgarh, IndiaDepartment of ENT & HNS, All India Institute of Medical Sciences, Raipur, Chhattisgarh, IndiaDepartment of Microbiology, All India Institute of Medical Sciences, Raipur, Chhattisgarh, IndiaDepartment of Pathology, All India Institute of Medical Sciences, Raipur, Chhattisgarh, India.
Mucormycosis is an invasive fungal infection caused by fungi of the order Mucorales. During the coronavirus disease 2019 (COVID-19), a rise in the number of COVID-19-associated mucormycosis (CAM) patients was reported globally. Cutaneous mucormycosis is the third most common presentation of mucormycosis.
View Article and Find Full Text PDFCutaneous mucormycosis shortly after renal transplantation.
CMAJ
October 2024
Division of Infectious Diseases (Lam), Department of Medicine, and Department of Pathology and Laboratory Medicine (Gray), University of California Los Angeles, Los Angeles, Calif.
Post COVID-19 mucormycosis in critical care settings: A prospective cohort study in a tertiary care center in Egypt.
J Infect Public Health
October 2024
Internal Medicine Department, Faculty of Medicine, Zagazig University, Zagazig 44519, Egypt. Electronic address:
Article Synopsis
- Mucormycosis has emerged as a serious fungal infection following COVID-19, raising concerns about mortality risk factors in affected patients.
- A study tracked 150 post-COVID-19 mucormycosis patients in the ICU from May 2021 to April 2022, revealing that 21% died, often linked to pneumonia and pulmonary embolism.
- Key risk factors for increased mortality included age over 60, steroid use, facial infections, uncontrolled diabetes, and high leukocyte counts.
A rare presentation of rhino-orbital-cutaneous mucormycosis in an immunocompetent patient: a case report.
Pan Afr Med J
August 2024
Department of Microbiology, Faculty of Medicine Airlangga University, Dr Soetomo Hospital Surabaya, Surabaya, Indonesia.
Article Synopsis
- * The case discussed involves a patient with an unusual presentation of rhino-orbital-cutaneous mucormycosis, starting as a localized abscess that progressed to a severe infection and headaches, raising suspicion of a fungal cause after ineffective antibiotic treatment.
- * Treatment involved the surgical removal of the right eye and debridement of infected tissue, followed by effective antifungal therapy with Amphotericin B, leading to recovery after four weeks.
Cutaneous mucormycosis infection owing to Rhizomucor variabilis presenting as recurrent lower limb ulceration and cellulitis in a diabetic patient.
Dermatol Online J
April 2024
Duke-NUS Medical School, Singapore National Skin Centre, Singapore.
Primary cutaneous mucormycosis is caused by environmental fungi and may complicate leg ulcers or traumatic wounds even in immunocompetent individuals. This case report highlights recurrent lower limb ulcers and cellulitis in a patient with type two diabetes mellitus, which was unresponsive to conventional antibiotic treatment. Histopathology revealed the diagnosis of cutaneous mucormycosis, and fungal cultures identified Rhizopus variabilis as the causative organism.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!